More News & Events...

In first-ever study, School of Medicine researchers to pair monoclonal antibody with body’s own killer-cell stimulator

A Case Western Reserve University School of Medicine researcher received a $2.5 million grant from Gilead Sciences, a California-based biopharmaceutical company, to see if two so-far separately used AIDS treatments are even more effective when used as a pair.